Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F91SE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,093
Award facts
- Contract value 100% obligated
- $48,092.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $48,092.77 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. The contract, issued on November 26, 2025, with a completion date of November 28, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026.
Enbrel is a biologic immunosuppressant medication used primarily to treat autoimmune conditions such as rheumatoid arthritis, and the SureClick auto-injector delivery system provides a patient-convenient administration method. AmerisourceBergen Drug Corp's role as a pharmaceutical prime vendor through the DLA supply chain ensures critical medical commodities reach military healthcare systems and other federal health programs. The competitively awarded delivery order reflects the contractor's established capability to meet federal pharmaceutical procurement requirements at scale, consistent with its broader portfolio of specialty medication and medical supply deliveries across multiple therapeutic domains supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F91SE?
SPE2DR26F91SE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F91SE worth?
The government has obligated $48,093 on SPE2DR26F91SE.
Is contract SPE2DR26F91SE an order under another contract?
Yes. SPE2DR26F91SE is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91SE competed?
The extent of competition for SPE2DR26F91SE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award